Journal article

Desvenlafaxine: A new antidepressant

L Bochsler, JS Olver, TR Norman

Medicine Today | Published : 2010

Abstract

Desvenlafaxine, a synthetic form of the major active metabolite of venlafaxine, is a new serotonin-noradrenaline reuptake inhibitor (SNRI) available for the treatment of major depressive disorder.

University of Melbourne Researchers

Citation metrics